Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel–Lindau disease: a case report - Top-Institutions - MDSpire

Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel–Lindau disease: a case report

  • By

  • Angelica Aja Dangca Alcoreza

  • Cheryn Song

  • Junyeop Lee

  • July 9, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear
    Massachusetts Eye and Ear

    Boston, Massachusetts

    Key Differentiators

    • Ophthalmology

  • #2

    University of Michigan Health – Kellogg Eye Center
    University of Michigan Health – Kellogg Eye Center

    Ann Arbor, Michigan

    Key Differentiators

    • Ophthalmology

  • #3

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, Florida

    Key Differentiators

    • Ophthalmology

Original Source(s)

Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel–Lindau disease: a case report

  • by Angelica Aja Dangca Alcoreza, Cheryn Song, Junyeop Lee

  • July 9, 2026

Related Content

The influence of age in the progression from pre-myopia to myopia onset: a 1 year retrospective analysis

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

ZEISS and Aier Group Sign Strategic Agreement

Agreement covers installation of 25 VISUMAX 800 femtosecond lasers across multiple Aier hospital locations

  • July 9, 2026

  • 2 min